Table 1.
TCA status at enrollment | ||||
---|---|---|---|---|
TCA-stable n (%) | TCA-progressed n (%) | Overall n (%) | P value | |
Total | 27 (100.0) | 34 (100.0) | 61 (100.0) | |
Eye | 0.43 | |||
OD | 20 (74.1) | 22 (64.7) | 42 (68.9) | |
OS | 7 (25.9) | 12 (35.3) | 19 (31.1) | |
Sex | 0.89 | |||
Male | 13 (48.1) | 17 (50.0) | 30 (49.2) | |
Female | 14 (51.9) | 17 (50.0) | 31 (50.8) | |
Glaucoma type | 0.96 | |||
POAG | 14 (51.9) | 18 (42.9) | 32 (52.5) | |
LTG | 8 (29.6) | 9 (26.5) | 17 (27.9) | |
CACG | 2 (7.4) | 2 (5.9) | 4 (6.6) | |
PG | 2 (7.4) | 3 (8.8) | 5 (8.2) | |
MMG | 1 (3.7) | 1 (2.9) | 2 (3.3) | |
Axenfeld syndrome | 0 (0.0) | 1 (2.9) | 1 (1.6) | |
HRT MRA (at baseline) | 0.27 | |||
Within normal limits | 7 (25.9) | 14 (41.2) | 21 (34.4) | |
Borderline | 6 (22.2) | 6 (17.6) | 12 (19.7) | |
Outside normal limits | 14 (51.9) | 14 (41.2) | 28 (45.9) |
POAG: primary open angle glaucoma; LTG: low tension glaucoma; CACG: chronic angle closure glaucoma; PG: pigmentary glaucoma; MMG: mixed mechanism glaucoma; MRA: moorfields regression analysis.